Results 111 to 120 of about 5,221 (170)

Effects of Esketamine Infusion by Patient-Controlled Intravenous Analgesia in Patients With Zoster-Associated Pain: A Retrospective Study. [PDF]

Med Sci Monit
Lou Y, Zhou S, Ying Y.
europepmc   +1 more source

Efficacy and safety evaluation of intravenous esketamine in alleviating perioperative depressive symptoms in Parkinson's disease: a randomized controlled trial. [PDF]

BMC Anesthesiol
Tan W, Gao Y, Su D, Ji L, Wang S.
europepmc   +1 more source

The effect of esketamine on emergence delirium or agitation in children after anesthesia-a systematic review and meta-analysis. [PDF]

BMC Anesthesiol
Yang W, Zhou L, Xue Y, Huang H.
europepmc   +1 more source

Esketamine-sufentanil PCA reduces postoperative depression state in elderly colorectal cancer patients: a randomized controlled trial. [PDF]

Sci Rep
Ding R, Wang D, Wang G, Lin Y, Wu D, Zhang M, Ren Y, Kang W, Lin G.   +8 more
europepmc   +1 more source

Effect of perioperative esketamine administration on the incidence of postoperative delirium: a systematic review and meta-analysis. [PDF]

BMC Anesthesiol
Tang X, Luo G, He Q, Liu X, Fu Q.
europepmc   +1 more source

Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study. [PDF]

Ther Adv Psychopharmacol
Cuomo A, McIntyre R, Koukouna D, Pinzi M, Pardossi S, Firenzuoli B, Barillà G, Carmellini P, Alamia A, Fagiolini A.   +9 more
europepmc   +1 more source

Ketamine for Depression in Serious Illness: Evidence, Safety, and Practical Approaches. [PDF]

J Pain Symptom Manage
Noufi P, Borris JB, Chammas D, McDermott CL, Ufere NN, Webb JA, Shalev D.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Esketamine for treatment resistant depression

Expert Review of Neurotherapeutics, 2019
Introduction: Treatment Resistant Depression (TRD) is a common and burdensome condition with poor outcomes and few treatment options. Esketamine is the S-enantiomer of ketamine and has recently been FDA approved in the United States for treating depression that has failed to respond to trials of two or more antidepressants.
Serdar Dursun, Pratap Chokka, Michael L Demas   +2 more
exaly   +5 more sources